XOM
48
6
ACN
52
-20
V
42
4
NRG
72
-2
NWS
47
2
WU
32
2
CVS
58
6
NAVI
40
4
HES
62
6
BWA
56
3
KLAC
63
-5
EXC
54
3
FOX
42
2
CTAS
53
-8
APA
30
6
CCL
68
4
WEC
45
2
HST
40
-12
PDCO
61
6
CHK
64
9
XOM
48
6
ACN
52
-20
V
42
4
NRG
72
-2
NWS
47
2
WU
32
2
CVS
58
6
NAVI
40
4
HES
62
6
BWA
56
3
KLAC
63
-5
EXC
54
3
FOX
42
2
CTAS
53
-8
APA
30
6
CCL
68
4
WEC
45
2
HST
40
-12
PDCO
61
6
CHK
64
9
Financhill
Back

Arcutis Biotherapeutics Vs. Zevra Therapeutics Industry Stock Comparison

Sell
26

ARQT
Arcutis Biotherapeutics

Last Price:
9.37
Seasonality Move:
-16.47%
Sell
46

ZVRA
Zevra Therapeutics

Last Price:
6.92
Seasonality Move:
-15.37%
Sell
26
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $9.36. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Zevra Therapeutics (ZVRA) is a Sell

Is Zevra Therapeutics a Buy, Sell or Hold?

  • The current Zevra Therapeutics [ZVRA] share price is $6.92. The Score for ZVRA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $9.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARQT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZVRA Stock Price Chart

What is Zevra Therapeutics's stock price today?

  • The Zevra Therapeutics share price today is $6.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVRA is experiencing slight selling pressure.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 41.78 Sell
Chaikin Money Flow: 1499214 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.76 - 10.82) Sell
Bollinger Bands (100): (8.44 - 10.34) Sell

ZVRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 43.24 Sell
Chaikin Money Flow: -305392 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.15 - 7.81) Sell
Bollinger Bands (100): (4.76 - 7.28) Buy

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.7 Sell
20-day SMA: 10.23 Sell
50-day SMA: 9.8 Sell
200-day SMA: 8.41 Buy
8-day EMA: 9.62 Sell
20-day EMA: 9.91 Sell
50-day EMA: 9.82 Sell
200-day EMA: 8.99 Buy

ZVRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.69 Sell
20-day SMA: 7.54 Sell
50-day SMA: 7.13 Sell
200-day SMA: 5.83 Buy
8-day EMA: 7.51 Sell
20-day EMA: 7.5 Sell
50-day EMA: 7.05 Sell
200-day EMA: 5.98 Buy

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.

Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.38 per share, and an increase next year of $1.02 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zevra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):